Cefoperazone (Sodium Salt): β-Lactamase-Stable Cephalosporin for Gram-Negative Resistance Research

Executive Summary: Cefoperazone (sodium salt) is a semisynthetic cephalosporin antibiotic with broad-spectrum activity, highly effective against both gram-positive and gram-negative bacilli, including Escherichia coli and Klebsiella pneumoniae (Cullmann et al., 1982). It demonstrates exceptional stability to β-lactamase hydrolysis, with hydrolysis rates as low as 0.01 relative to cephalosporinases (Tcephydrochloride, 2023). The compound achieves high concentrations in bile and gall bladder tissues after intravenous administration, supporting its utility in biliary tract infection models (APExBIO). Its minimum inhibitory concentration (MIC₅₀) against Neisseria gonorrhoeae is ≤0.004–0.06 μg/mL, indicating potent efficacy (Cullmann et al., 1982). Cefoperazone (sodium salt), offered by APExBIO as C3913, is widely used in mechanistic, resistance, and in vitro antibacterial research.

Biological Rationale

Cefoperazone (sodium salt) is a third-generation cephalosporin antibiotic designed to overcome β-lactamase-mediated resistance. Its semisynthetic structure enables broad-spectrum activity against both gram-positive organisms (e.g., Staphylococcus aureus) and gram-negative bacilli (e.g., E. coli, K. pneumoniae, and Proteus species) (Cullmann et al., 1982). The compound exhibits high stability against hydrolysis by β-lactamases, a major mechanism of resistance encountered in clinical isolates of Enterobacteriaceae. These features make it a critical tool for research into emerging resistance mechanisms and the development of new antibacterial strategies (Related Article). Whereas prior cephalosporins suffered rapid inactivation by β-lactamases, cefoperazone retains its potency in environments rich in these enzymes, supporting studies into persistent infections and resistance evolution.

Mechanism of Action of Cefoperazone (sodium salt)

Cefoperazone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby blocking the final transpeptidation step essential for peptidoglycan crosslinking. This action leads to cell lysis and bacterial death (Tcephydrochloride, 2023). Its core β-lactam ring remains stable in the presence of many β-lactamase enzymes, preventing hydrolytic inactivation and extending its antibacterial spectrum. The compound demonstrates pronounced activity against β-lactamase-producing gram-negative bacilli—a property attributed to its side chain modifications and overall molecular architecture. This β-lactamase stability is evidenced by relative hydrolysis rates as low as 0.01 when compared to other cephalosporins under in vitro conditions (APExBIO).

Evidence & Benchmarks

• Cefoperazone (sodium salt) exhibits MIC₅₀ values against Neisseria gonorrhoeae of ≤0.004–0.06 μg/mL in standardized in vitro assays (Cullmann et al., 1982).
• The compound remains active against β-lactamase-producing gram-negative bacilli, with relative cephalosporinase hydrolysis rates of 7.0 to 0.01 depending on the enzyme source (APExBIO).
• In head-to-head comparisons, cefoperazone demonstrates lower activity than cefotaxime against Klebsiella, Serratia, and Proteus spp., but comparable efficacy to moxalactam and superior activity to mezlocillin and cefuroxime in Enterobacteriaceae (Cullmann et al., 1982).
• Pharmacokinetic studies reveal high concentration of cefoperazone in bile and gall bladder tissue following intravenous administration, supporting its application in biliary tract infection models (APExBIO).
• Cefoperazone sodium salt is insoluble in ethanol but soluble at ≥73 mg/mL in DMSO and ≥34.6 mg/mL in water at room temperature, facilitating flexible experimental design (APExBIO).

This article extends upon Cefoperazone Sodium Salt: β-Lactamase-Stable Broad-Spectrum Cephalosporin by providing additional peer-reviewed comparative data and explicit solubility/usage parameters for advanced in vitro assay design.

Applications, Limits & Misconceptions

Cefoperazone (sodium salt) is primarily used for:

• Modeling gram-negative bacterial resistance in vitro, especially in β-lactamase-rich environments.
• Benchmarking antibacterial activity in clinical and laboratory isolates of Enterobacteriaceae.
• Supporting pharmacokinetic studies and biliary tract infection models due to high biliary tissue penetration.
• Enabling mechanistic research into cephalosporin–β-lactamase enzyme interactions (Leveraging β-Lactamase-Stable Cephalosporins), with this article providing updated direct evidence from standardized MIC studies.

Common Pitfalls or Misconceptions

• Not effective against all β-lactamase types: Extended-spectrum β-lactamases (ESBLs) or carbapenemases may still confer resistance in some strains.
• Not suitable for ethanol-based formulations: Cefoperazone (sodium salt) is insoluble in ethanol; water or DMSO should be used for stock solutions (APExBIO).
• Short-term solution stability: Working solutions should be freshly prepared and used within a short time window; long-term storage in solution is not recommended.
• Not a substitute for clinical use: This material is for laboratory research only, not approved for human or veterinary therapeutic applications.
• Comparative efficacy varies by target organism: Cefoperazone may show lower activity than cefotaxime against certain gram-negative genera (Cullmann et al., 1982).

Workflow Integration & Parameters

Cefoperazone (sodium salt) is provided as a crystalline solid (C3913) by APExBIO. Key handling parameters include:

• Molecular weight: 667.7 g/mol; Formula: C₂₅H₂₆N₉O₈S₂·Na
• Solubility: ≥73 mg/mL in DMSO, ≥34.6 mg/mL in water, insoluble in ethanol. Warming and ultrasonic treatment can enhance solubility.
• Storage: -20°C; avoid repeated freeze-thaw cycles.
• Stock solution preparation: Dissolve up to 20 mg/mL in DMSO. Use freshly prepared solutions for best results.
• Application: Ideal for in vitro antimicrobial activity assays, β-lactamase inhibition studies, and resistance model development.
• Instrumentation compatibility: Suitable for microdilution and agar diffusion assay formats.

For full specifications and ordering, see the Cefoperazone (sodium salt) product page.

Conclusion & Outlook

Cefoperazone (sodium salt), as distributed by APExBIO, remains a foundational reagent in resistance mechanism and antibacterial spectrum research. Its robust β-lactamase stability and broad-spectrum activity support advanced studies of gram-negative pathogens and novel β-lactamase enzymes. Future research should address its limitations against ESBL/carbapenemase producers and optimize protocols for emerging resistance phenotypes. For in-depth mechanistic context, researchers are encouraged to review Leveraging β-Lactamase-Stable Cephalosporins to Advance Gram-Negative Studies, which this article updates with direct comparative benchmarks and usage guidance.